Glenmark Pharmaceuticals makes it to DJSI for fourth consecutive year

Glenmark Pharmaceuticals today announced that the company has been listed in the Dow Jones Sustainability Index (DJSI) under the category of emerging markets for the fourth consecutive year, the company notified via a statement.

“Our inclusion in the coveted Dow Jones Sustainability Indices (DJSI) for the fourth consecutive year is a validation of our commitment to sustainability and reiterates our consistent performance across all sustainability indicators. The DJSI inclusion strengthens our resolve to uphold our sustainability strategy that encompasses the Environmental, Social and Governance (ESG) principles to make a positive difference to our operations, stakeholders, communities and the planet at large,” said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals.

The statement claimed that over 800 companies across sectors from the emerging markets were assessed, out of which around 108 made it to the prestigious index this year, including 15 from India. Glenmark is one of the only five companies from the pharmaceuticals, biotechnology and lifesciences sector to be featured in the DJSI Emerging Markets 2021.